Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06270953 · ClinicalTrials.gov registry record
Non-invasive Monitoring: Impact on Patient Management and Outcomes
A clinical trial, sponsored by Turtle Shell Technologies Pvt..
- Completed
- Registry status
- 54
- Enrollment target
NCT06270953 is a clinical trial that has completed, run by Turtle Shell Technologies Pvt.. The registered enrollment target is 54 participants.
The verdict
NCT06270953 has completed, sponsored by Turtle Shell Technologies Pvt..
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
Enhancing patient monitoring in SNFs and ALFs is crucial due to challenges in recognizing deteriorating health. Gaps in vital sign checks lead to missed indicators and adverse outcomes. Turtle Shell Technologies' Dozee Pro NX offers continuous non-invasive monitoring, alerting healthcare providers of vital sign changes. This clinical study aims to evaluate Dozee Pro Nx's impact on patient outcomes, practitioner efficiency, and healthcare costs in SNFs and ALFs, addressing gaps in care delivery.
Interventions
- DEVICE Dozee Pro NX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-01-19 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06270953
The ClinicalTrials.gov registry entry for NCT06270953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Turtle Shell Technologies Pvt., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dozee Pro NX is the first listed.
NCT06270953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06270953 about?
NCT06270953 is a clinical study titled "Non-invasive Monitoring: Impact on Patient Management and Outcomes". Enhancing patient monitoring in SNFs and ALFs is crucial due to challenges in recognizing deteriorating health. Gaps in vital sign checks lead to missed indicators and adverse outcomes. Turtle Shell Technologies' Dozee Pro NX offers continuous non-invasive monitoring, alerting healthcare providers o...
What is the current status of trial NCT06270953?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2024-01-19. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT06270953?
The interventions under investigation include: Dozee Pro NX (DEVICE).
Who is sponsoring clinical trial NCT06270953?
This trial is sponsored by Turtle Shell Technologies Pvt., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.